Literature DB >> 10259966

Evaluation in the community mental health centers program: a bold new reproach?

W Neigher, J Ciarlo, C Hoven, K Kirkhart, G Landsberg, E Light, F Newman, E L Struening, L Williams, C Windle, J R Woy.   

Abstract

The Federal Community Mental Health Centers Program (CMHC)-from 1963 to 1981-was heralded as a revolution in mental health care. Championed by many, and severely criticized by others, the actual impact of the program on the nation's mental health remains unclear. The authorization to evaluate the CMHC Program came originally from congressional legislation (PL 90-174), and later from the policies and regulations of NIMH under a series of Federal laws, notably PL 94-63. From 1976-1980, two dominant evaluation strategies were prevalent: funds expended by NIMH each year for studies of CMHC services or program-wide evaluations, and a much larger expenditure by CMHCs to conduct their own, independent evaluations following federal guidelines. As the Center's Program was turned over to the states in the form of block grants (PL 97-35), a group of professionals involved with setting and carrying out federal CMHC evaluation policy of both varieties met in public forum to debate the impact of these two evaluation approaches. While some participants cited gains in evaluation technology and impact upon local management of CMHCs, others found the lack of a coordinated and systematic approach to evaluating the CMHC Program to have been an opportunity missed. The impact of CMHC evaluation efforts are also discussed in terms of their major contribution to the field of evaluation research as a whole.

Entities:  

Mesh:

Year:  1982        PMID: 10259966     DOI: 10.1016/0149-7189(82)90001-5

Source DB:  PubMed          Journal:  Eval Program Plann        ISSN: 0149-7189


  2 in total

1.  Selecting a rating scale for evaluating services to the chronically mentally ill.

Authors:  R S Green; E J Gracely
Journal:  Community Ment Health J       Date:  1987

Review 2.  Quality-of-life instruments for severe chronic mental illness. Implications for pharmacotherapy.

Authors:  M Becker
Journal:  Pharmacoeconomics       Date:  1995-03       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.